It’s time for another edition of the Reading Roundup featuring the top blog posts from March 2017. Start off your weekend by kicking back and catching up on what the pharmaceutical industry was reading in March. Data Quality and Data Integrity: What is the Difference?
An oldie but goodie, tops the list for March 2017! Data integrity is a hot topic in the pharmaceutical industry right now. Hear from industry experts about the difference between data quality and data integrity.
Looking Ahead – 2017 Pharmaceutical Industry Trends
Learn from six industry experts as they tackle the hard questions on what the global pharmaceutical industry needs to move forward from the most important developments and innovations to the biggest hurdles of 2017.
Are you in the development and/or implementation phase of an automated production system? Are you considering revising your data integrity strategy plan? Get the GAMP® guidelines you need to achieve your desired outcome.
Biopharmaceutical Manufacturing Process Validation and Quality Risk Management
This article was up for the 2016 Article of the Year Awards by Pharmaceutical Engineering® magazine. Learn how process validation and quality risk management have impacted the biopharmaceutical manufacturing industry and what's in store for the future.
How Leader Actions and Behaviors Influence Quality Culture
Pharmaceutical Engineering® magazine published a quarterly report on Quality Culture, in the November/December 2016 issue. This article from the report reviews how quality culture is impacting the pharmaceutical industry and what you can do at your organization to implement a culture of quality.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...
